Consistently, we show here that ISO treatment upregulated miR-137 through promoting the phosphorylation of c-Jun at Ser73, consequently resulting in the inhibition of GSK3β-HSP70 protein translation, MMP-2 protein elevation, and BC cell invasion. This evidence concerns the gene JUN and breast cancer.